BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 25381700)

  • 1. Fanconi anemia and solid malignancies in childhood: a national retrospective study.
    Malric A; Defachelles AS; Leblanc T; Lescoeur B; Lacour B; Peuchmaur M; Maurage CA; Pierron G; Guillemot D; d'Enghien CD; Soulier J; Stoppa-Lyonnet D; Bourdeaut F
    Pediatr Blood Cancer; 2015 Mar; 62(3):463-70. PubMed ID: 25381700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
    Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL
    Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review.
    Freycon C; Sepulchre E; Lavallée VP; Mitchell D; MacMillan ML; Vezina C; Goudie C
    Clin Genet; 2024 Apr; ():. PubMed ID: 38658784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin for treatment of cytopenias in children and young adults with Fanconi anemia.
    Pollard JA; Furutani E; Liu S; Esrick E; Cohen LE; Bledsoe J; Liu CW; Lu K; de Haro MJR; Surrallés J; Malsch M; Kuniholm A; Galvin A; Armant M; Kim AS; Ballotti K; Moreau L; Zhou Y; Babushok D; Boulad F; Carroll C; Hartung H; Hont A; Nakano T; Olson T; Sze SG; Thompson AA; Wlodarski MW; Gu X; Libermann TA; D'Andrea A; Grompe M; Weller E; Shimamura A
    Blood Adv; 2022 Jun; 6(12):3803-3811. PubMed ID: 35500223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin recognition by FAAP20 expands the complex interface beyond the canonical UBZ domain.
    Wojtaszek JL; Wang S; Kim H; Wu Q; D'Andrea AD; Zhou P
    Nucleic Acids Res; 2014 Dec; 42(22):13997-4005. PubMed ID: 25414354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is wrong with Fanconi anemia cells?
    Cantor SB; Brosh RM
    Cell Cycle; 2014; 13(24):3823-7. PubMed ID: 25486020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abundance of the Fanconi anaemia core complex is regulated by the RuvBL1 and RuvBL2 AAA+ ATPases.
    Rajendra E; Garaycoechea JI; Patel KJ; Passmore LA
    Nucleic Acids Res; 2014 Dec; 42(22):13736-48. PubMed ID: 25428364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary breast cancer syndromes and genetic testing.
    Rich TA; Woodson AH; Litton J; Arun B
    J Surg Oncol; 2015 Jan; 111(1):66-80. PubMed ID: 25381882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective FANCI binding by a fanconi anemia-related FANCD2 mutant.
    Sato K; Ishiai M; Takata M; Kurumizaka H
    PLoS One; 2014; 9(12):e114752. PubMed ID: 25489943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.
    Candido-dos-Reis FJ; Song H; Goode EL; Cunningham JM; Fridley BL; Larson MC; Alsop K; Dicks E; Harrington P; Ramus SJ; de Fazio A; Mitchell G; Fereday S; Bolton KL; Gourley C; Michie C; Karlan B; Lester J; Walsh C; Cass I; Olsson H; Gore M; Benitez JJ; Garcia MJ; Andrulis I; Mulligan AM; Glendon G; Blanco I; Lazaro C; Whittemore AS; McGuire V; Sieh W; Montagna M; Alducci E; Sadetzki S; Chetrit A; Kwong A; Kjaer SK; Jensen A; Høgdall E; Neuhausen S; Nussbaum R; Daly M; Greene MH; Mai PL; Loud JT; Moysich K; Toland AE; Lambrechts D; Ellis S; Frost D; Brenton JD; Tischkowitz M; Easton DF; Antoniou A; Chenevix-Trench G; Gayther SA; Bowtell D; Pharoah PD; ; ;
    Clin Cancer Res; 2015 Feb; 21(3):652-7. PubMed ID: 25398451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
    Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
    Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway.
    Kim TM; Son MY; Dodds S; Hu L; Luo G; Hasty P
    Nucleic Acids Res; 2015 Jan; 43(2):893-903. PubMed ID: 25520194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.
    Maxwell KN; Wubbenhorst B; D'Andrea K; Garman B; Long JM; Powers J; Rathbun K; Stopfer JE; Zhu J; Bradbury AR; Simon MS; DeMichele A; Domchek SM; Nathanson KL
    Genet Med; 2015 Aug; 17(8):630-8. PubMed ID: 25503501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA repair. Mechanism of DNA interstrand cross-link processing by repair nuclease FAN1.
    Wang R; Persky NS; Yoo B; Ouerfelli O; Smogorzewska A; Elledge SJ; Pavletich NP
    Science; 2014 Nov; 346(6213):1127-30. PubMed ID: 25430771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome.
    Durno CA; Sherman PM; Aronson M; Malkin D; Hawkins C; Bakry D; Bouffet E; Gallinger S; Pollett A; Campbell B; Tabori U;
    Eur J Cancer; 2015 May; 51(8):977-83. PubMed ID: 25883011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
    Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
    J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.
    Zhang MY; Churpek JE; Keel SB; Walsh T; Lee MK; Loeb KR; Gulsuner S; Pritchard CC; Sanchez-Bonilla M; Delrow JJ; Basom RS; Forouhar M; Gyurkocza B; Schwartz BS; Neistadt B; Marquez R; Mariani CJ; Coats SA; Hofmann I; Lindsley RC; Williams DA; Abkowitz JL; Horwitz MS; King MC; Godley LA; Shimamura A
    Nat Genet; 2015 Feb; 47(2):180-5. PubMed ID: 25581430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Kotsopoulos J; Lubinski J; Gronwald J; Cybulski C; Demsky R; Neuhausen SL; Kim-Sing C; Tung N; Friedman S; Senter L; Weitzel J; Karlan B; Moller P; Sun P; Narod SA;
    Int J Cancer; 2015 Sep; 137(5):1136-46. PubMed ID: 25482078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.